AN2 Therapeutics, Inc. Common Stock

ANTXNASDAQUSD
4.79 USD
0.06 (1.25%)🟢PRE MARKET (AS OF 05:45 AM EDT)
🟢Market: OPEN
Open?$4.81
High?$4.88
Low?$4.74
Prev. Close?$4.80
Volume?556
Avg. Volume?384.3K
VWAP?$4.86
Rel. Volume?0.00x
Bid / Ask
Bid?$4.05 × 100
Ask?$5.53 × 100
Spread?$1.48
Midpoint?$4.79
Valuation & Ratios
Market Cap?172.8M
Shares Out?36.0M
Float?25.9M
Float %?72.2%
P/E Ratio?N/A
P/B Ratio?3.26
EPS?-$0.98
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.87Strong
Quick Ratio?6.87Strong
Cash Ratio?2.29Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A
P/B?
3.26FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-4.0CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-66.3%WEAK
ROA?
-56.8%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$152.8M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
Employees
21
Market Cap
156.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2022-03-25
Address
1300 EL CAMINO REAL, SUITE 100
MENLO PARK, CA 94025
Phone: (650) 331-9090